Johnson & Johnson Will Discontinue Talc-Primarily Based Infant Powder Globally In 2023 The New York Times
The aspect of the firm selling prescription drugs and healthcare devices will retain the J&J name. There’s no investigation that definitively links Johnson & Johnson’s talc-based infant powder with ovarian cancer, but the medical consensus on the security of talc when employed cosmetically remains murky. According to the American Cancer Society, it is not clear whether items that include talc (and never contain asbestos) could nonetheless improve the threat for cancer, as studies in each humans and lab animals have created conflicting final results. The society bases its conclusions on the Planet Wellness Organization’s International Agency for Analysis on Cancer,...